Global shifts are rewriting the rules of clinical supply. Rising costs, regional regulations, and material scarcity mean planners must rethink strategies or risk costly disruptions.
- Managing Supply Chain Risk In Scale-Up And Multisite Trials
- Global Clinical Supply — Confronting Persistent Challenges With Strategic Action
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Building A Culture Of Compliance In Clinical Supply
- Global Clinical Supply Chain in Emerging Markets: Reliability, Compliance, Access
- Clinical Supply Is Not A Fix-It Function. It's A Planning Function.
- Sales & Operations Planning for Small Teams: Aligning Clinical Supply
- The Trends Shaping Clinical Trial Supply
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Key Considerations For Selecting Flexible Fillers
Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
Planning For The Return And Destruction Of Your Product
Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Is Your Clinical Supply Strategy Ready For EU CTR?
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
5 Tips To Put The Right Systems In Place For Successful Clinical Trials
Before you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity? Learn about key upgrades that can help you streamline operations and reduce risk.
-
Complex Randomization Delivered Successfully
Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain
In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.